Market Overview

UPDATE: Stifel Upgrades IMAX

Share:
Related IMAX
Netflix, HBO Now And More: What Wedbush Analysts Are Watching
IMAX's Record April Debut: 'Furious 7' Grosses $20.8M Globally In IMAX Theatres
Lions Gate (LGF) Faces Ban in Russia for Child 44 Movie - Analyst Blog (Zacks)

In a report released Monday, Stifel analyst Benjamin Mogil upgraded IMAX (NYSE: IMAX) from Hold to Buy with a $32 price target.

Analysts at Stifel have previously tracked IMAX's EBITDA per screen declines due to cost troubles limiting operating leverage and low trends in box office. Stifel now anticipates high JRSA margin expansion in result to expected change operating leverage and EBITDA per screen growth.

Mogil claimed IMAX China concerns are overblown because of CJ CGV and Wanda conducting most of the installations for 2014, 2015 and anticipates accelerated installs in 2016 with the next Avatar.

Stifel's $32 price target is given a 2015 estimated EBITDA multiple of 13.8x minority interest.

Latest Ratings for IMAX

DateFirmActionFromTo
Apr 2015Canaccord GenuityUpgradesHoldBuy
Apr 2015MacquarieInitiates Coverage onOutperform
Feb 2015Canaccord GenuityDowngradesBuyHold

View More Analyst Ratings for IMAX
View the Latest Analyst Ratings

Posted-In: Benjamin Mogil StifelUpgrades Price Target Analyst Ratings

 

Related Articles (IMAX)

Around the Web, We're Loving...

Get Benzinga's Newsletters